Rafferty Asset Management, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,622,892
-41.1%
206,287
+6.8%
0.03%
-38.6%
Q2 2023$7,853,987
+3.0%
193,115
+22.7%
0.04%
-15.4%
Q1 2023$7,626,539
-5.5%
157,443
-25.5%
0.05%
-23.5%
Q4 2022$8,071,047
+24.5%
211,450
+63.7%
0.07%
-1.4%
Q3 2022$6,484,000
+33.2%
129,158
+6.3%
0.07%
+53.3%
Q2 2022$4,869,000
-18.1%
121,552
-23.7%
0.04%
+28.6%
Q1 2022$5,947,000
+5.0%
159,390
+12.1%
0.04%
+16.7%
Q4 2021$5,662,000
+91.4%
142,153
+78.8%
0.03%
+50.0%
Q3 2021$2,958,000
+15.2%
79,491
+30.9%
0.02%
+25.0%
Q2 2021$2,567,000
-4.9%
60,737
+6.5%
0.02%
-11.1%
Q1 2021$2,699,000
+208.1%
57,004
+297.3%
0.02%
+100.0%
Q4 2020$876,000
-56.9%
14,347
-67.0%
0.01%
-64.0%
Q3 2020$2,034,000
+106.7%
43,513
+124.4%
0.02%
+78.6%
Q2 2020$984,000
+213.4%
19,391
+175.8%
0.01%
+7.7%
Q1 2020$314,000
-89.0%
7,030
-88.2%
0.01%
-70.5%
Q4 2019$2,865,000
-5.3%
59,653
-33.3%
0.04%
-6.4%
Q3 2019$3,024,000
-33.0%
89,424
-10.9%
0.05%
-40.5%
Q2 2019$4,514,000
+9.0%
100,312
-8.9%
0.08%
+17.9%
Q1 2019$4,143,000110,0660.07%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders